Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Cells|November 26, 2022
Cell-Free DNA Sequencing Reveals Gene Variants in DNA Damage Repair Genes Associated with Prognosis of Prostate Cancer PatientsVerena Lieb, Amer Abdulrahman, Katrin Weigelt, et al.
International Journal of Cancer|March 15, 2011
MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screeningSven Wach, Elke Nolte, Jaroslaw Szczyrba, et al.
European Journal of Heart Failure|February 6, 2020
Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trialRobert Stöhr, Vincent M Brandenburg, Gunnar H Heine, et al.
Clinical Cardiology|March 25, 2022
Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolismRobert Stöhr, Timm Dirrichs, Kinan Kneizeh, et al.
Cancers|January 1, 2020
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer PatientsAmer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
The Journal of Pathology. Clinical Research|August 9, 2016
Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype-genotype correlationTilman T Rau, Raja Atreya, Daniela Aust, et al.
Cancers|May 21, 2020
CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node StageMarkus Eckstein, Elena Epple, Rudolf Jung, et al.
European Urology Open Science|June 16, 2025
Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial CancerMaximilian Haas, Roman Mayr, Danijel Sikic, et al.
Cancers|September 19, 2020
Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer PatientsPaul König, Markus Eckstein, Rudolf Jung, et al.
Life (Basel, Switzerland)|May 28, 2022
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer PatientsAlexander Fichte, Angela Neumann, Katrin Weigelt, et al.
Pageof 9